Inhibikase Therapeutics (IKT) Stock: Buy, Sell, or Hold?
IKT - Inhibikase Therapeutics, Inc. Common Stock
$2.00
0.00 (0.00%)
▲
5d:
-2.44%
30d:
-20.63%
90d:
-2.44%
HOLD
MODERATE Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When IKT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IKT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IKT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IKT is currently trading at $2.00, which is considered oversold relative to its 30-day fair value range of $2.09 to $2.44.
Technical Outlook: Technically, IKT is in a strong uptrend. Immediate support is located at $1.93, while resistance sits at $2.33.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $6.00 (+200.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IKT is in a strong uptrend. Immediate support is located at $1.93, while resistance sits at $2.33.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $6.00 (+200.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.09 -
$2.44
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (58/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 200.0% below Wall St target ($6.00)
- NEUTRAL: Bottoming setup forming (58/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$2.09 -
$2.44
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.93
Resistance Level
$2.34
Current Trend
Strong Uptrend
Technical data as of
Oct 5, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.62
Wall Street Target
$6.00
(+200.0%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: October 05, 2026 2:32 PM ET
Data refreshes hourly during market hours. Next update: 3:32 PM
Data refreshes hourly during market hours. Next update: 3:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IKT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$294 | 65 BUY |
|
REGN
Regeneron Pharmaceutical… |
BUY
27 analysts |
$853 | 53 HOLD |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
19 analysts |
$644 | 59 HOLD |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$36 | 54 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$32 | 57 HOLD |
